Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome
Background: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adverse prognostic factors. However, it is unclear whether loco-regional lymph node deposits are effectively the root of secondary metastases or only an indicator of competence of the primary tumour to s...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420301687 |
id |
doaj-485f54bda6f3493aa15d1c17955dc341 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David Venet Danai Fimereli Françoise Rothé Bram Boeckx Marion Maetens Samira Majjaj Ghizlane Rouas Maria Capra Giuseppina Bonizzi Federica Contaldo Christine Galant Martine Piccart Giancarlo Pruneri Denis Larsimont Diether Lambrechts Christine Desmedt Christos Sotiriou |
spellingShingle |
David Venet Danai Fimereli Françoise Rothé Bram Boeckx Marion Maetens Samira Majjaj Ghizlane Rouas Maria Capra Giuseppina Bonizzi Federica Contaldo Christine Galant Martine Piccart Giancarlo Pruneri Denis Larsimont Diether Lambrechts Christine Desmedt Christos Sotiriou Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome EBioMedicine Breast cancer Metastatic dissemination Axillary lymph node Distant metastasis |
author_facet |
David Venet Danai Fimereli Françoise Rothé Bram Boeckx Marion Maetens Samira Majjaj Ghizlane Rouas Maria Capra Giuseppina Bonizzi Federica Contaldo Christine Galant Martine Piccart Giancarlo Pruneri Denis Larsimont Diether Lambrechts Christine Desmedt Christos Sotiriou |
author_sort |
David Venet |
title |
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
title_short |
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
title_full |
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
title_fullStr |
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
title_full_unstemmed |
Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
title_sort |
phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome |
publisher |
Elsevier |
series |
EBioMedicine |
issn |
2352-3964 |
publishDate |
2020-06-01 |
description |
Background: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adverse prognostic factors. However, it is unclear whether loco-regional lymph node deposits are effectively the root of secondary metastases or only an indicator of competence of the primary tumour to spread to distant organs. Methods: Here, we investigated the evolutionary trajectories of primary tumour, ALN and distant metastasis samples from 16 estrogen-receptor (ER)-positive lymph node-positive BC patients. Low-pass whole genome sequencing was performed to infer somatic copy number aberrations and the phylogenetic profiles for all patients were obtained. Findings: We show that lymph nodes and distant metastases shared a common origin in only 25% of the cases highlighting that the predominant route of metastatic dissemination is the direct seeding of tumour cells from the primary tumour to distant organs, independently of lymph node metastasis. Noticeably, patients sharing a common origin significantly have worse prognosis. Interpretation: Our results shed light on the routes on which tumour cells metastasize and their role in disease progression in ER-positive BC. Funding: This work has received financial support from Les Amis de l'Institut Bordet, MEDIC, the Breast Cancer Research Foundation (BCRF), the Belgian Fonds National de la Recherche Scientifique (F.R.S-FNRS) and from a grant of the Région Wallonne. |
topic |
Breast cancer Metastatic dissemination Axillary lymph node Distant metastasis |
url |
http://www.sciencedirect.com/science/article/pii/S2352396420301687 |
work_keys_str_mv |
AT davidvenet phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT danaifimereli phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT francoiserothe phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT bramboeckx phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT marionmaetens phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT samiramajjaj phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT ghizlanerouas phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT mariacapra phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT giuseppinabonizzi phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT federicacontaldo phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT christinegalant phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT martinepiccart phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT giancarlopruneri phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT denislarsimont phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT dietherlambrechts phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT christinedesmedt phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome AT christossotiriou phylogeneticreconstructionofbreastcancerrevealstworoutesofmetastaticdisseminationassociatedwithdistinctclinicaloutcome |
_version_ |
1724682673161502720 |
spelling |
doaj-485f54bda6f3493aa15d1c17955dc3412020-11-25T03:04:09ZengElsevierEBioMedicine2352-39642020-06-0156102793Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcomeDavid Venet0Danai Fimereli1Françoise Rothé2Bram Boeckx3Marion Maetens4Samira Majjaj5Ghizlane Rouas6Maria Capra7Giuseppina Bonizzi8Federica Contaldo9Christine Galant10Martine Piccart11Giancarlo Pruneri12Denis Larsimont13Diether Lambrechts14Christine Desmedt15Christos Sotiriou16J.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumLaboratory of Translational Genetics, VIB Center for Cancer Biology, Campus Gasthuisberg, O&N IV Herestraat 49 - box 912, 3000, Leuven, Belgium; Laboratory of Translational Genetics, Department of Human Genetics, Katholieke Universiteit Leuven, O&N IV Herestraat 49 - box 912, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, Belgium; Laboratory for Translational Breast Cancer Research, Department of Oncology, Katholieke Universiteit Leuven, O&N I Herestraat 49 - box 818, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, ItalyBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, ItalyBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, ItalyDepartment of Pathology, Cliniques Universitaires Saint Luc, Avenue Hippocrate 10, 1200, Brussels, BelgiumMedical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, BelgiumBiobank for Translational Medicine Unit, Department of Pathology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy; Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133, Milan, Italy; School of Medicine, University of Milan, via Festa del Perdono 7, 20122, Milano, Milan, ItalyDepartment of Pathology, Institut Jules Bordet, Bld de Waterloo 121, 1000, Brussels, BelgiumLaboratory of Translational Genetics, VIB Center for Cancer Biology, Campus Gasthuisberg, O&N IV Herestraat 49 - box 912, 3000, Leuven, Belgium; Laboratory of Translational Genetics, Department of Human Genetics, Katholieke Universiteit Leuven, O&N IV Herestraat 49 - box 912, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, Belgium; Laboratory for Translational Breast Cancer Research, Department of Oncology, Katholieke Universiteit Leuven, O&N I Herestraat 49 - box 818, 3000, Leuven, BelgiumJ.C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo 121, 1000, Brussels, Belgium; Corresponding author.Background: In breast cancer (BC), axillary lymph node (ALN) involvement is one of the strongest adverse prognostic factors. However, it is unclear whether loco-regional lymph node deposits are effectively the root of secondary metastases or only an indicator of competence of the primary tumour to spread to distant organs. Methods: Here, we investigated the evolutionary trajectories of primary tumour, ALN and distant metastasis samples from 16 estrogen-receptor (ER)-positive lymph node-positive BC patients. Low-pass whole genome sequencing was performed to infer somatic copy number aberrations and the phylogenetic profiles for all patients were obtained. Findings: We show that lymph nodes and distant metastases shared a common origin in only 25% of the cases highlighting that the predominant route of metastatic dissemination is the direct seeding of tumour cells from the primary tumour to distant organs, independently of lymph node metastasis. Noticeably, patients sharing a common origin significantly have worse prognosis. Interpretation: Our results shed light on the routes on which tumour cells metastasize and their role in disease progression in ER-positive BC. Funding: This work has received financial support from Les Amis de l'Institut Bordet, MEDIC, the Breast Cancer Research Foundation (BCRF), the Belgian Fonds National de la Recherche Scientifique (F.R.S-FNRS) and from a grant of the Région Wallonne.http://www.sciencedirect.com/science/article/pii/S2352396420301687Breast cancerMetastatic disseminationAxillary lymph nodeDistant metastasis |